✦ LIBER ✦

999 Immunomonitoring in stage II melanoma patients treated with adjuvant GM-CSF

✍ Scribed by I. Timofeev; G. Kharkevitch; Z. Kadagidze; L.V. Demidov

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of oxaliplatin, docetax

✍ Frederick Locke; Joseph I. Clark; Thomas F. Gajewski 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 268 KB

HER2/neu Peptide-Based Vaccines, with GM

✍ Kathy Schiffman; Mary L. Disis 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 105 KB

KRASMutation is Associated with Worse Pr

✍ Lee, Dae-Won; Kim, Kyung Ju; Han, Sae-Won; Lee, Hyun Jung; Rhee, Ye Young; Bae, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 351 KB

Local and Distant Immunity Induced by In

✍ Howard L. Kaufman; Dae Won Kim; Gail DeRaffele; Josephine Mitcham; Rob S. Coffin 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 844 KB

Equivalent survival in patients with adv

✍ X. Carcopino; G. Houvenaeghel; M. Buttarelli; B. Esterni; A. Tallet; A. Goncalve 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Gene-expression signature of tumor recur

✍ María Dolores Giráldez; Juan José Lozano; Míriam Cuatrecasas; Virginia Alonso-Es 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 245 KB